Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Raw Materials (2016 - 2025)

Historic Raw Materials for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $12.5 million.

  • Standard Biotools' Raw Materials fell 7504.05% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year decrease of 7504.05%. This contributed to the annual value of $13.0 million for FY2024, which is 742.17% up from last year.
  • Latest data reveals that Standard Biotools reported Raw Materials of $12.5 million as of Q3 2025, which was down 7504.05% from $9.8 million recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Raw Materials registered a high of $50.0 million during Q3 2024, and its lowest value of $9.3 million during Q4 2021.
  • For the 5-year period, Standard Biotools' Raw Materials averaged around $18.7 million, with its median value being $12.6 million (2022).
  • In the last 5 years, Standard Biotools' Raw Materials surged by 19267.05% in 2024 and then crashed by 8008.93% in 2025.
  • Standard Biotools' Raw Materials (Quarter) stood at $9.3 million in 2021, then skyrocketed by 80.48% to $16.9 million in 2022, then decreased by 28.02% to $12.1 million in 2023, then rose by 7.42% to $13.0 million in 2024, then dropped by 4.39% to $12.5 million in 2025.
  • Its Raw Materials stands at $12.5 million for Q3 2025, versus $9.8 million for Q2 2025 and $19.9 million for Q1 2025.